Antimicrobial lipids at the skin surface

The skin surface represents our interface with the external environment, and as such, is our first line of defense against microbial colonization and infection. Lipids at the skin surface are thought to underlie at least part of an antimicrobial barrier. Some of these lipids are synthesized in the epidermis and are carried to the surface as cells differentiate, whereas others are secreted onto the surface from the sebaceous glands. One such group, free sphingoid bases, are known to have broad antimicrobial activity, and our previous studies demonstrate their presence at the skin surface. Free sphingoid bases may be generated by enzymatic hydrolysis of epidermal ceramides. In addition, our preliminary results demonstrate potent antibacterial activity associated with two specific fatty acids derived from sebaceous triglycerides. Most remarkably, one of these fatty adds (sapienic add, C16:1Δ6), in combination with a low concentration of ethanol, is very effective against methicillin-resistant Staphylococcus aureus (MRSA). In fact, this combination was far more effective than mupirocin with or without ethanol. Mupirocin is a "gold standard" for activity against MRSA.

[1]  R. Medzhitov,et al.  Innate immune recognition: mechanisms and pathways , 2000, Immunological reviews.

[2]  R. Isseroff,et al.  Lamellar body-enriched fractions from neonatal mice: preparative techniques and partial characterization. , 1985, The Journal of investigative dermatology.

[3]  G. K. Johnson,et al.  Production of β-Defensin Antimicrobial Peptides by the Oral Mucosa and Salivary Glands , 1999, Infection and Immunity.

[4]  S. Ladhani Recent developments in staphylococcal scalded skin syndrome. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  E. Christophers,et al.  Contrasting disease patterns in psoriasis and atopic dermatitis , 2004, Archives of Dermatological Research.

[6]  A. Quinn,et al.  Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. , 2001, The Journal of investigative dermatology.

[7]  R. Novick,et al.  Equivalence of Lauric Acid and Glycerol Monolaurate as Inhibitors of Signal Transduction in Staphylococcus aureus , 2000, Journal of bacteriology.

[8]  B. Dale Periodontal epithelium: a newly recognized role in health and disease. , 2002, Periodontology 2000.

[9]  G. Imokawa,et al.  Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. , 2002, The Journal of investigative dermatology.

[10]  M. Ståhle-Bäckdahl,et al.  The Human Cationic Antimicrobial Protein (hCAP18), a Peptide Antibiotic, Is Widely Expressed in Human Squamous Epithelia and Colocalizes with Interleukin-6 , 1999, Infection and Immunity.

[11]  P. A. Raj,et al.  Structure of human salivary histatin 5 in aqueous and nonaqueous solutions. , 1998, Biopolymers.

[12]  G. K. Johnson,et al.  Discovery of new human β-defensins using a genomics-based approach , 2001 .

[13]  S. Krisanaprakornkit,et al.  Expression of the Peptide Antibiotic Human β-Defensin 1 in Cultured Gingival Epithelial Cells and Gingival Tissue , 1998, Infection and Immunity.

[14]  P. Shivananda,et al.  Incidence of post operative wound infection and their antibiogram in a teaching and referral hospital. , 1998, Indian Journal of Medical Sciences.

[15]  P. Wertz,et al.  New acylceramide in native and reconstructed epidermis. , 2003, The Journal of investigative dermatology.

[16]  O. Oncul,et al.  The evaluation of nosocomial infection during 1-year-period in the burn unit of a training hospital in Istanbul, Turkey. , 2002, Burns : journal of the International Society for Burn Injuries.

[17]  P. Wertz,et al.  Sphingolipids of the stratum corneum and lamellar granules of fetal rat epidermis. , 1984, The Journal of investigative dermatology.

[18]  P. Wertz,et al.  Covalently bound lipids of human stratum corneum. , 1989, The Journal of investigative dermatology.

[19]  F. Vandenesch,et al.  Glycerol Monolaurate Inhibits theProduction of1-Lactamase, Toxic ShockSyndrome Toxin-i, andOtherStaphylococcal Exoproteins byInterfering withSignal Transduction , 1994 .

[20]  Noble Skin bacteriology and the role of Staphylococcus aureus in infection , 1998, The British journal of dermatology.

[21]  P. Wertz,et al.  Thin-layer chromatographic analyses of lipids in different layers of porcine epidermis and oral epithelium. , 1991, Archives of oral biology.

[22]  J. Burtenshaw,et al.  The Mechanism of Self-Disinfection of the Human Skin and its Appendages , 1942, Journal of Hygiene.

[23]  R. Freinkel,et al.  Lipid composition and acid hydrolase content of lamellar granules of fetal rat epidermis. , 1985, The Journal of investigative dermatology.

[24]  R. Locksley,et al.  The Instructive Role of Innate Immunity in the Acquired Immune Response , 1996, Science.

[25]  G. K. Johnson,et al.  Discovery of new human beta-defensins using a genomics-based approach. , 2001, Gene.

[26]  H. Thormar,et al.  Killing of Gram‐positive cocci by fatty acids and monoglycerides Note , 2001, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[27]  E. Unanue,et al.  Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. , 1997, Current opinion in immunology.

[28]  H. Green,et al.  The cornified envelope of terminally differentiated human epidermal keratinocytes consists of cross-linked protein , 1977, Cell.

[29]  A. V. van Winkelhoff,et al.  Salivary lactoferrin and low-Mr mucin MG2 in Actinobacillus actinomycetemcomitans-associated periodontitis. , 1999, Journal of clinical periodontology.

[30]  I. Loudon Necrotising fasciitis, hospital gangrene, and phagedena , 1994, The Lancet.

[31]  F. Oppenheim,et al.  Structural features of salivary function. , 1993, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[32]  E. Veerman,et al.  Biochemical composition of human saliva in relation to other mucosal fluids. , 1995, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[33]  P. Wertz,et al.  The nature of the epidermal barrier: biochemical aspects , 1996 .

[34]  H. Shinefield,et al.  Antimicrobial activity of sphingosines. , 1992, The Journal of investigative dermatology.

[35]  P. A. Raj,et al.  Bactericidal activity and poly-L-proline II conformation of the tandem repeat sequence of human salivary mucin glycoprotein (MG2). , 1998, Archives of biochemistry and biophysics.

[36]  C. Janeway,et al.  The Toll receptor family and microbial recognition. , 2000, Trends in microbiology.

[37]  P. Wertz,et al.  Free sphingosines in oral epithelium. , 1995, Comparative Biochemistry and Physiology Part B Comparative Biochemistry.

[38]  P. Wertz,et al.  Regional variation in content, composition and organization of porcine epithelial barrier lipids revealed by thin-layer chromatography and transmission electron microscopy. , 1995, Archives of oral biology.

[39]  K. Sandhoff,et al.  Deficiency of Epidermal Protein-Bound ω-Hydroxyceramides in Atopic Dermatitis , 2002 .

[40]  U. Holmskov Collectins and collectin receptors in innate immunity , 2000, APMIS. Supplementum.

[41]  V. Nizet,et al.  Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. , 2001, The Journal of investigative dermatology.

[42]  D. Fearon,et al.  Innate pathways that control acquired immunity. , 1997, Current opinion in immunology.

[43]  P. Wertz,et al.  Molecular models of the intercellular lipid lamellae in mammalian stratum corneum. , 1989, The Journal of investigative dermatology.

[44]  H. Maibach,et al.  Topical Drug Bioavailability, Bioequivalence, and Penetration , 1993, Springer US.

[45]  H. J. Kolmos,et al.  The surgical team as a source of postoperative wound infections caused by Streptococcus pyogenes. , 1997, The Journal of hospital infection.

[46]  P. Wertz,et al.  Ceramidase activity in porcine epidermis , 1990, FEBS letters.

[47]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[48]  A. Quinn,et al.  Expression of the Peptide Antibiotics Human β Defensin-1 and Human β Defensin-2 in Normal Human Skin , 2001 .

[49]  D. Fearon Seeking wisdom in innate immunity , 1997, Nature.

[50]  P. Wertz,et al.  Free sphingosines in porcine epidermis. , 1989, Biochimica et biophysica acta.

[51]  D. Downing,et al.  Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro. , 1996, The Journal of investigative dermatology.

[52]  P. Wertz,et al.  Covalently bound ω-hydroxyacylsphingosine in the stratum corneum , 1987 .

[53]  B. W. Barry Vehicle Effect: What Is an Enhancer? , 1993 .

[54]  Veien The clinician's choice of antibiotics in the treatment of bacterial skin infection , 1998, The British journal of dermatology.

[55]  Tomas Ganz,et al.  Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.

[56]  Thestrup‐Pedersen Bacteria and the skin: clinical practice and therapy update , 1998, The British journal of dermatology.

[57]  L. Landmann The epidermal permeability barrier , 2004, Anatomy and Embryology.

[58]  C. Janeway,et al.  An ancient system of host defense. , 1998, Current opinion in immunology.

[59]  G. Ronnett,et al.  Plunc, a Member of the Secretory Gland Protein Family, Is Up-regulated in Nasal Respiratory Epithelium after Olfactory Bulbectomy* , 2002, The Journal of Biological Chemistry.

[60]  S. Carelli,et al.  Ceramide composition of the psoriatic scale. , 1993, Biochimica et biophysica acta.

[61]  O. Conneely,et al.  Regulation of epidermal Langerhans cell migration by lactoferrin , 2000, Immunology.

[62]  F. Vandenesch,et al.  Glycerol monolaurate inhibits the production of beta-lactamase, toxic shock toxin-1, and other staphylococcal exoproteins by interfering with signal transduction , 1994, Journal of bacteriology.

[63]  T. Mirzabekov,et al.  Membrane channel formation by antimicrobial protegrins. , 1999, Biochimica et biophysica acta.

[64]  Abeck,et al.  Staphylococcus aureus colonization in atopic dermatitis and its therapeutic implications , 1998, The British journal of dermatology.

[65]  J. Schröder,et al.  Isolation and Characterization of Human β-Defensin-3, a Novel Human Inducible Peptide Antibiotic* , 2001, The Journal of Biological Chemistry.

[66]  J. Goudswaard,et al.  Measurement of Salivary Lysozyme , 1978, Journal of dental research.

[67]  S. Shah,et al.  Sphingosines: antimicrobial barriers of the skin. , 1993, Acta dermato-venereologica.

[68]  R. Wilkins,et al.  The BSP30 salivary proteins from cattle, LUNX/PLUNC and von Ebner's minor salivary gland protein are members of the PSP/LBP superfamily of proteins. , 2002, Biochimica et biophysica acta.

[69]  Takaaki Ohtake,et al.  Biology and clinical relevance of naturally occurring antimicrobial peptides. , 2002, The Journal of allergy and clinical immunology.

[70]  G. Imokawa,et al.  Purification and Biochemical Characterization of Membrane-bound Epidermal Ceramidases from Guinea Pig Skin (*) , 1995, The Journal of Biological Chemistry.

[71]  G. M. Gray,et al.  isolation and , 2022 .

[72]  R. Bals,et al.  Human β‐defensin 4: a novel inducible peptide with a specific salt‐sensitive spectrum of antimicrobial activity , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[73]  L. Ford,et al.  Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids , 1996, Antimicrobial agents and chemotherapy.

[74]  P. Elias,et al.  Lamellar body secretory response to barrier disruption. , 1992, The Journal of investigative dermatology.

[75]  Ronald N. Germain,et al.  The Art of the Probable: System Control in the Adaptive Immune System , 2001, Science.

[76]  H. Shinefield,et al.  Topical sphingolipids in antisepsis and antifungal therapy , 1995, Clinical and experimental dermatology.

[77]  S. Krisanaprakornkit,et al.  Epithelial antimicrobial peptides: review and significance for oral applications. , 1998, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[78]  I. Tokimitsu,et al.  Relationship between covalently bound ceramides and transepidermal water loss (TEWL) , 2000, Archives of Dermatological Research.

[79]  M. E. Stewart,et al.  Free sphingosines of human skin include 6-hydroxysphingosine and unusually long-chain dihydrosphingosines. , 1995, Journal of Investigative Dermatology.

[80]  G. Imokawa Lipid abnormalities in atopic dermatitis. , 2001, Journal of the American Academy of Dermatology.

[81]  P. Elias,et al.  Coordinate Regulation of Epidermal Differentiation and Barrier Homeostasis , 2001, Skin Pharmacology and Physiology.

[82]  J. Lambris,et al.  Complement and innate immunity. , 2000, Immunopharmacology.

[83]  K. Sandhoff,et al.  Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. , 2002, The Journal of investigative dermatology.

[84]  P. Wertz,et al.  Lamellar granule biogenesis: a role for ceramide glucosyltransferase, lysosomal enzyme transport, and the Golgi. , 1998, The journal of investigative dermatology. Symposium proceedings.